Valuation: Abbott India Limited

Market Cap 551B 5.87B 5.34B 4.93B 4.45B 8.4B 8.7B 59.29B 23.49B 296B 22.04B 21.57B 937B P/E 2027 *
31x
P/E 2028 * 28.6x
Enterprise Value 526B 5.6B 5.09B 4.7B 4.25B 8.02B 8.3B 56.55B 22.41B 282B 21.02B 20.58B 894B EV / Sales 2027 *
6.96x
EV / Sales 2028 * 6.3x
Free-Float
24.47%
Yield 2027 *
2.6%
Yield 2028 * 2.77%
1 day-1.74%
1 week-2.74%
Current month+1.41%
1 month-0.44%
3 months-4.15%
6 months-7.09%
Current year-10.72%
1 week 25,901
Extreme 25901
26,780
1 month 24,670.1
Extreme 24670.1
27,420
Current year 24,670.1
Extreme 24670.1
29,250
1 year 24,670.1
Extreme 24670.1
30,598
3 years 21,983.4
Extreme 21983.4
35,921.55
5 years 15,525
Extreme 15525
35,921.55
10 years 3,996
Extreme 3996
35,921.55
Manager TitleAgeSince
Chief Executive Officer 46 14/06/2025
Director of Finance/CFO 53 06/05/2025
Director of Finance/CFO - 01/04/2025
Director TitleAgeSince
Director/Board Member 70 01/03/2011
Chairman 71 13/08/2026
Director/Board Member 61 29/10/2019
Change 5-day change 1-year change 3-year change Capi.($)
-1.74%-2.74%-11.19%+13.24% 5.95B
-0.56%+1.78%+40.65%+144.08% 1,286B
-1.01%+0.23%+41.68%+88.38% 688B
-0.32%+0.42%+25.86%+112.99% 521B
+1.14%+2.04%+42.51%+72.81% 386B
-1.47%-2.05%+56.91%+42.87% 364B
+1.27%+1.72%+28.34%+63.11% 302B
+0.37%-0.23%+3.25%+38.05% 287B
-0.57%-0.23%+35.83%+72.54% 252B
-0.67%-0.87%+35.26%+125.23% 208B
Average -0.42%+1.90%+29.91%+77.33% 430B
Weighted average by Cap. -0.38%+3.25%+36.59%+98.39%

Financials

2027 *2028 *
Net sales 75.57B 805M 731M 676M 610M 1.15B 1.19B 8.12B 3.22B 40.56B 3.02B 2.96B 128B 83.24B 887M 805M 744M 672M 1.27B 1.31B 8.95B 3.55B 44.67B 3.33B 3.26B 141B
Net income 17.81B 190M 172M 159M 144M 271M 281M 1.91B 758M 9.56B 712M 697M 30.27B 19.28B 205M 187M 172M 156M 294M 304M 2.07B 821M 10.35B 771M 754M 32.78B
Net Debt -25.49B -271M -247M -228M -206M -388M -402M -2.74B -1.09B -13.68B -1.02B -997M -43.33B -26.94B -287M -261M -241M -218M -411M -425M -2.9B -1.15B -14.46B -1.08B -1.05B -45.79B
Projected Income Statement - Annual - Abbott India Limited
Logo Abbott India Limited
Abbott India Limited is an India-based pharmaceutical company. The Company is involved in product development, manufacturing, sales, and customer service. It distributes products and solutions in multiple therapeutic categories, such as women's health, gastroenterology, cardiology, metabolic disorders and primary care. It operates in a single reportable business segment, which is Pharmaceuticals. The Company’s products include Arachitol Nano, Digeraft, Influvac, Colospa, Duphalac, Librax, Creon, Duphaston, Prothiaden, Cremaffin, Duvadilan, Thyronorm, Cremaffin Plus, Ganaton, Udiliv, Digene, Heptral, Vertin, Zolfresh, Citrosoda UTI, Digene Insta On The Go, Digeraft tablet, Duphaston OD, Pneumoshield 14, Prothiaden Neu, Vonefi, Levesam, and LOBATE M Skin Cream, among others. The Company sells its products through independent distributors primarily within India.
Employees
3,679
Date Price Change Volume
16/11/26 ₹25,953.25 -1.74% 270
13/11/26 ₹26,413.45 -0.71% 480
12/11/26 ₹26,603.60 +1.93% 342
11/11/26 ₹26,100.20 -2.06% 8,245
09/11/26 ₹26,648.25 -0.14% 2,278
Trader
Investor
Global
-
Quality
ESG MSCI
-
MarketScreener Ratings - Abbott India Limited
  1. Stock Market
  2. Stocks
  3. ABBOTINDIA Stock